Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension Study.
AuteursSitbon O, Sahay S, Escribano Subías P, Zolty RL, Kingrey JF, Ryan JJ, Sobol I, Sood N, Benza RL, Channick RN, Chin KM, Frantz RP, Ghofrani HA, Hemnes AR, McLaughlin VV, Vachiéry JL, Zamanian RT, Ter Veer A, Roscigno RF, Mottola D, Parsley E, Aranda R, Zisman LS, Howard LS
The effects of lacosamide, pregabalin, and tapentadol on peripheral nerve excitability: A randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects.
AuteursNochi Z, Pia H, Bloms-Funke P, Boesl I, Caspani O, Chapman SC, di Pietro G, Fardo F, Genser B, Goetz M, Jiang B, Kostenko AV, Lebrun L, Leone CM, Li T, Möller-Grell N, Mouraux A, Pelz B, Pogatzki-Zahn E, Rong C, Schilder A, Schnetter E, Schubart K, Tracey I, Truini A, Vincent KF, Vollert J, Wanigasekera V, Wittayer M, Treede RD, Tankisi H, Finnerup NB
Real-world validation of a prognostic clinical index to predict steroid response in acute severe colitis: a single tertiary centre retrospective study.
AuteursBouillon V, De Terwangne C, Liefferinckx C, Minsart C, Amininejad L, Franchimont D, Cremer A
Spironolactone in patients on chronic haemodialysis at high risk of adverse cardiovascular outcomes (ALCHEMIST): a multicentre, double-blind, randomised, placebo-controlled trial and updated meta-analysis.
AuteursRossignol P, Zannad F, Massy Z, Azizi M, Chorfa F, Coadic J, Ferreira JP, Saraiva F, Mottier D, Guillemin F, Ngueyon Sime W, Bouali S, Rossignol B, Nortier J, Simon I, Robino C, Davin M, Bataille PM, Chantrel F, Castin N, Esnault V, Kazes I, Hannedouche T, Kamar N, Achard JM, Fenerol C, Achard-Hottelart C, Dimitrov Y, Girerd N, Maucourt-Boulch D, Frimat L
